Medi Assist Ser. Q3 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 6 Aug 2026 | Insurance | Market Cap: ₹2.6K Cr
Premium under management grew 16.6% YoY as of December 31, 2024, with Group premiums growing ~15% YoY and Retail premiums growing 31% YoY. Medi Assist expects continued growth driven by expanded partnerships and increasing health insurance penetration in India.
From Medi Assist Ser.'s Q3 FY25 earnings-call transcript · updated 23 Aug 2026.
Price
₹361
Market Cap
₹2.6K Cr
P/E Ratio
26.4
How does Medi Assist Ser. rank in Insurance?
Compare Medi Assist Ser. against every Insurance company this quarter on revenue, margins and earnings-call signals.
Medi Assist Ser. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹242 Cr, net profit ₹54 Cr.
Full financials →📊 Revenue & Sales Performance
📈 Profitability & Margins
- →Medi Assist expects continued growth driven by expanded partnerships and increasing health insurance penetration in India.
- →Group segment premiums grew ~14.7-15% YoY; retail premiums saw a 31% YoY growth, indicating strong momentum.
- →Margin improvements are expected with adjusted steady-state margins targeting around 23%, excluding one-time expenses.
- →The company is focused on improving operational efficiency via hubs of excellence and AI-driven fraud prevention, delivering 2.5x growth in savings to insurers.
- →Acquisition of new insurers and integration of acquisitions like Paramount aim to boost scale and profitability.
- →Return on Net Worth for 9 months is strong at 30.2% (annualized 17.6%), and RoCE is 14% (annualized 18.7%), showing healthy capital efficiency.
- →Enabling capital raises (such as the 350 CR fundraise) support strategic growth initiatives.
- →Overall, results and commentary indicate a positive outlook for earnings, operating profits, and EPS growth fueled by market expansion, technology, and improved claim management.
🏗️ Capital Expenditure Plans
- →A significant fundraise approval of INR 350 crores has been taken as an enabling resolution for future growth and capital deployment (Page 9).
- →The fundraise is intended to support strategic initiatives and growth, including the announced Paramount acquisition (Page 9).
- →No specific timing or detailed use of funds is disclosed yet; updates will be provided as Board and shareholder approvals progress (Page 9).
- →Medi Assist continues to invest in technology and AI capabilities, including their proprietary AI for predicting out-of-pocket expenses and AI-powered fraud detection, which supports operational efficiency and claims processing (Pages 6, 5).
- →Creation of hubs of excellence for claims processing to improve operational efficiency (Page 5).
💰 Fundraising & Capital Structure
- →The company has taken approval for a significant fundraising (enabling resolution) to support future growth.
- →Specific details on timing and exact usage of the funds have not been disclosed yet, as per regulatory guidelines.
- →The fundraise is intended to enable growth opportunities over the next few years, including deployments related to the announced Paramount acquisition.
- →The company will update investors as approvals are received from the Board and shareholders.
- →No explicit information was provided about whether the fundraising will be through debt or equity; it's positioned as a general capital structure and allocation strategy evaluation.
📋 Order Book & Pipeline
- →As of December 31, 2024, the contract liability (order book equivalent) stood at INR 227 crores, indicating a healthy pipeline of unrecognized revenue.
- →No sharp decline or significant change in yield from the contract liability was observed.
- →The company expects some lag in revenue recognition due to the nature of revenue over the policy periods.
- →Growth in premiums was strong, with a 16.6% year-on-year increase in Premiums Under Management (PUM), showing positive momentum for future business inflows.
- →The company continues to add new insurers and expand portfolios, especially in Retail and Government segments, which would contribute to future order inflows.
- →The Paramount acquisition is pending regulatory approval, expected within the current quarter, which may add to order backlog and business volume once closed.
Key Metrics
Frequently Asked Questions
What were Medi Assist Ser. Q3 FY25 results?
Premium under management grew 16.6% YoY as of December 31, 2024, with Group premiums growing ~15% YoY and Retail premiums growing 31% YoY. Medi Assist expects continued growth driven by expanded partnerships and increasing health insurance penetration in India.
What is Medi Assist Ser. share price analysis?
Medi Assist Ser. currently shows a neutral. The stock trades at a P/E of 26.4 with a market cap of ₹2,605 Cr. Investors should review the full earnings analysis for detailed insights.
Is Medi Assist Ser. planning capital expenditure?
A significant fundraise approval of INR 350 crores has been taken as an enabling resolution for future growth and capital deployment (Page 9).
Keep Medi Assist Ser. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.